James Guo
Vice President
pharmaceutical
Henlius Biopharmaceuticals
China
Biography
The company Vice President and Secretary of the Board, Mr. Guo Xinjun, is mainly responsible for strategic planning and drug regulatory affairs. Mr. Guo Xinjun has many years of biopharmaceutical development and production experience, and he is familiar with all types of national laws and regulations. He has been involved in the development of national second-class drug China's first listed recombinant human granulocyte colony-stimulating factor (rhG-CSF) injection. Previously acting as one of the shareholders of Hangzhou Taishi Biological Technology Co., Ltd., as well as the deputy general manager of Zhejiang Cifu Medicine Co., Ltd, Mr. Guo has accumulated extensive industry experience.
Research Interest
pharmaceutical
